These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Elevation of serum Krebs von den Lunge-6 levels in patients with tubulointerstitial nephritis and uveitis syndrome. Kase S; Kitaichi N; Namba K; Miyazaki A; Yoshida K; Ishikura K; Ikeda M; Nakashima T; Ohno S Am J Kidney Dis; 2006 Dec; 48(6):935-41. PubMed ID: 17162148 [TBL] [Abstract][Full Text] [Related]
23. Pneumocyte biomarkers KL-6 and surfactant protein D reflect the distinct findings of high-resolution computed tomography in nonspecific interstitial pneumonia. Ichiyasu H; Ichikado K; Yamashita A; Iyonaga K; Sakamoto O; Suga M; Kohrogi H Respiration; 2012; 83(3):190-7. PubMed ID: 21555868 [TBL] [Abstract][Full Text] [Related]
24. [The sequential changes of the serum levels of KL-6, SP-D, and DLCO were followed for a long term in a case of acute bird fancier's lung]. Takao T; Hanehira T; Zenke Y; Shikama J; Igei H; Inoue E; Yoshizawa Y Arerugi; 2009 Oct; 58(10):1433-40. PubMed ID: 19901513 [TBL] [Abstract][Full Text] [Related]
25. [Clinical significance of serum surfactant proteins A and D in idiopathic interstitial pneumonia]. Honda Y Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Dec; 34 Suppl():181-5. PubMed ID: 9216212 [TBL] [Abstract][Full Text] [Related]
26. Analysis of KL-6 and SP-D as disease markers in bird fancier's lung. Janssen R; Grutters JC; Sato H; van Velzen-Blad H; Zanen P; Kohno N; Welsh KI; du Bois RM; van den Bosch JM Sarcoidosis Vasc Diffuse Lung Dis; 2005 Mar; 22(1):51-7. PubMed ID: 15881280 [TBL] [Abstract][Full Text] [Related]
27. [New serum markers to monitor treatment of acute exacerbation of interstitial lung disease]. Otsuka M; Takahashi H; Fujisima T; Nishiyama K; Kon H; Outi H; Imai Y; Sakon O; Shiratori M; Abe S Nihon Kokyuki Gakkai Zasshi; 2001 Apr; 39(4):298-302. PubMed ID: 11481832 [TBL] [Abstract][Full Text] [Related]
29. [Surfactant proteins A and D as biomarkers of disease activity in diffuse interstitial pneumonia]. Abe S; Takahashi H Nihon Kokyuki Gakkai Zasshi; 2000 Mar; 38(3):157-65. PubMed ID: 10846395 [TBL] [Abstract][Full Text] [Related]
30. Clinical significance of the serum surfactant protein D and KL-6 levels in patients with measles complicated by interstitial pneumonia. Arai Y; Obinata K; Sato Y; Hisata K; Tadokoro R; Tawa T; Kinoshita K Eur J Pediatr; 2001 Jul; 160(7):425-9. PubMed ID: 11475580 [TBL] [Abstract][Full Text] [Related]
31. Prognostic value of circulating KL-6 in idiopathic pulmonary fibrosis. Yokoyama A; Kondo K; Nakajima M; Matsushima T; Takahashi T; Nishimura M; Bando M; Sugiyama Y; Totani Y; Ishizaki T; Ichiyasu H; Suga M; Hamada H; Kohno N Respirology; 2006 Mar; 11(2):164-8. PubMed ID: 16548901 [TBL] [Abstract][Full Text] [Related]
32. Surfactant protein D and KL-6 as serologic indicators of Pneumocystis carinii pneumonia in a child with acute lymphoblastic leukemia. Takahashi T; Ebihara Y; Manabe A; Tsuji K; Nakamura T; Nakahata T; Iwamoto A J Med; 2001; 32(1-2):41-51. PubMed ID: 11321887 [TBL] [Abstract][Full Text] [Related]
34. CA15-3 and cancer associated serum antigen assays are alternatives to the KL-6 assay for measuring serum MUC-1 levels in patients with interstitial lung disease associated with polymyositis/dermatomyositis. Wong RC; Klingberg S; Wilson R J Rheumatol; 2002 Sep; 29(9):2021-2; author reply 2022. PubMed ID: 12233905 [No Abstract] [Full Text] [Related]
35. [KL-6 in patients with interstitial pneumonitis]. Hamada H; Sakatani M; Ueda E Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Jul; 34(7):771-7. PubMed ID: 8810758 [TBL] [Abstract][Full Text] [Related]
36. Marked increase in serum KL-6 and surfactant protein D levels during the first 4 weeks after treatment predicts poor prognosis in patients with active interstitial pneumonia associated with polymyositis/dermatomyositis. Arai S; Kurasawa K; Maezawa R; Owada T; Okada H; Fukuda T Mod Rheumatol; 2013 Sep; 23(5):872-83. PubMed ID: 22983659 [TBL] [Abstract][Full Text] [Related]
37. [Significance of serum surfactant protein-D (SP-D) level in patients with pulmonary tuberculosis]. Kondo A; Oketani N; Maruyama M; Taguchi Y; Yamaguchi Y; Miyao H; Mashima I; Oono M; Wada K; Tsuchiya T; Takahashi H; Abe S Kekkaku; 1998 Oct; 73(10):585-90. PubMed ID: 9844346 [TBL] [Abstract][Full Text] [Related]
38. [Lung injury and serum markers]. Suwabe A Rinsho Byori; 2002 Nov; 50(11):1061-6. PubMed ID: 12491603 [TBL] [Abstract][Full Text] [Related]
39. Levels of surfactant proteins A and D and KL-6 are elevated in the induced sputum of chronic obstructive pulmonary disease patients: a sequential sputum analysis. Ishikawa N; Hattori N; Tanaka S; Horimasu Y; Haruta Y; Yokoyama A; Kohno N; Kinnula VL Respiration; 2011; 82(1):10-8. PubMed ID: 21474912 [TBL] [Abstract][Full Text] [Related]
40. [Immunity tests for respiratory diseases--SP-A, SP-D, KL-6]. Kambe M; Ohshimo S; Kohno N Rinsho Byori; 2007 Apr; 55(4):381-7. PubMed ID: 17511270 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]